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Summary
All mature Saccharomyces cerevisiae sphingolipids
comprise inositolphosphorylceramides containing
C26:0 or C24:0 fatty acids and either phytosphin-
gosine or dihydrosphingosine. Here we analysed the
lipid proﬁle of lag1D lac1D mutants lacking acyl-CoA-
dependent ceramide synthesis, which require the
reverse ceramidase activity of overexpressed Ydc1p
for sphingolipid biosynthesis and viability. These
cells, termed 2D.YDC1, make sphingolipids containing
exclusively dihydrosphingosine and an abnormally
wide spectrum of fatty acids with between 18 and 26
carbon atoms. Like wild-type cells, 2D.YDC1 cells stop
growing when exposed to Aureobasidin A (AbA), an
inhibitor of the inositolphosphorylceramide synthase
AUR1, yet their ceramide levels remain very low. This
ﬁnding argues against a current hypothesis saying
that yeast cells do not require inositolphosphorylce-
ramides and die in the presence of AbA only because
ceramides build up to toxic concentrations. Moreover,
W303lag1D lac1D ypc1D ydc1D cells, reported to be
AbA resistant, stop growing on AbA after a certain
number of cell divisions, most likely because AbA
blocks the biosynthesis of anomalous inositolphos-
phorylsphingosides. Thus, data argue that inositol-
phosphorylceramides of yeast, the equivalent of
mammalian sphingomyelins, are essential for growth.
Data also clearly conﬁrm that wild-type strains, when
exposed toAbA, immediately stop growing because of
ceramide intoxication, long before inositolphospho-
rylceramide levels become subcritical.
Introduction
In Saccharomyces cerevisiae, the inositolphosphory-
lceramides (IPCs), mannosyl-IPCs (MIPCs) and
inositolphosphoryl-MIPCs [M(IP)2Cs] are major compo-
nents of the plasma membrane (Fig. 1) (Dickson and
Lester, 1999). Moreover, as in mammalian cells, dihy-
drosphingosine (DHS), phytosphingosine (PHS), their
1-phosphorylated derivatives as well as ceramides have
been proposed to act as signal transduction molecules
governing heat stress responses, endocytosis, GPI protein
transport, ubiquitin-dependent degradation of membrane
channels and progression through G1 (Dickson and
Lester, 2002; Sims et al., 2004; Dickson et al., 2006;
Dickson, 2008).
The biosynthesis of ceramide is dependent on the
longevity assurance gene LAG1 and its close homologue
LAC1 (D’mello et al., 1994) (Fig. 1), which are members
of a large gene family with homologues present through-
out the eukaryotic kingdom (Winter and Ponting, 2002;
Obeid and Hannun, 2003). Yeast Lag1p and Lac1p are
functionally redundant and deletions of LAG1 or LAC1 do
not cause an abnormal growth phenotype, whereas the
concomitant deletion of LAG1 and LAC1 causes a signiﬁ-
cant growth defect in the W303 genetic background and
the same double deletion is lethal in the YPK9 back-
ground (Jiang et al., 1998; Barz and Walter, 1999; Guillas
et al., 2001). Lag1p or Lac1p are functional only in
complex with Lip1p (Fig. 1), a small, single-span endo-
plasmic reticulum (ER) membrane protein, deletion of
which severely reduces the growth rate of yeast cells
(Vallée and Riezman, 2005).
Using multicopy suppressor screens, it has been found
that overexpression of YPC1 or YDC1 (Fig. 1) improves
the slow growth phenotype of W303 lag1D lac1D (2D.
W303) cells (Schorling et al., 2001) and suppresses the
lethality of the lag1D lac1D double mutation in the YPK9
background (Jiang et al., 2004). Ypc1p and Ydc1p are two
highly homologous membrane proteins of the ER. They
show 54% identity over their entire length and catalyse
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the hydrolysis of ceramides in vitro, i.e. they act as cera-
midases (Fig. 1). In vitro, as observedwithmany enzymes,
Ypc1p can also catalyse the reverse reaction, i.e. the
condensation of [3H]palmitate with PHS or DHS (Mao
et al., 2000a). Ydc1p, contrary to Ypc1p, has been shown
to hydrolyse only DHS-containing ceramides and exhibits
only very weak reverse activity in vitro (Mao et al., 2000b).
The reverse activities of Ypc1p and Ydc1p thus provide an
alternative way of making ceramide (Fig. 1), which can
explain why the overexpression of YPC1 or YDC1 can
improve or rescue the growth of lag1D lac1D (2D) cells or
render yeast cells resistant to the toxic effect of fumonisin
B1, a speciﬁc inhibitor of the acyl-CoA-dependent ceram-
ide synthase (Mao et al., 2000a,b) (Fig. 1).
Metabolic labelling experiments suggest the existence
of yet another, third way of making sphingolipid-like
compounds. Indeed, W303 lag1D lac1D ypc1D ydc1D
(4D.W303) cells are viable and able to incorporate
[3H]DHS, [3H]inositol and 32PO4 into lipids X1 and X2,
two mild base-resistant, but not yet characterized lipids
(Schorling et al., 2001).
Initially, yeast cells were assumed to require IPCs
because the IPC synthase AUR1 is essential (Fig. 1) and
becauseAureobasidinA (AbA), a highly speciﬁc inhibitor of
Aur1p, rapidly kills growing yeast cells (99% dead cells
within 1 h) (Endo et al., 1997; Nagiec et al., 1997). The
requirement for IPCs has however been questioned, since
W303 lag1D lac1D, W303 lag1D lac1D ypc1D ydc1D and
lip1D cells grew well in the presence of high concentrations
of AbA (Schorling et al., 2001; Vallée and Riezman, 2005),
and because sphingolipids are altogether dispensable for
certain yeast cells harbouring a gain of function suppressor
allele in the lyso-phosphatidate acyltransferase SLC1
(Nagiec et al., 1993). The AbA resistance of W303 lag1D
lac1D, W303 lag1D lac1D ypc1D ydc1D and lip1D cells led
to the hypothesis that IPCs are dispensable for cell growth
and that AbA kills wild-type (wt) cells by causing the accu-
mulation of toxic levels of ceramides rather than by depriv-
ing them of IPCs.
Here we set out to further investigate the physiological
potential of alkaline ceramidases and in particular of
YDC1 by examining sphingolipid proﬁles and stress resis-
tance of yeast cells, which neither possess acyl-CoA-
dependent ceramide synthases nor a third way of making
inositolphosphorylsphingoids and thus depend for ceram-
ide biosynthesis on YDC1. In the course of this study we
realized that such cells could be used to answer the
question as to whether or not IPCs are essential for cell
survival of yeast cells. We ﬁnd that IPCs are essential for
growth but this becomes only apparent in lag1D lac1D
strains, which do not accumulate toxic ceramides when
IPC synthase activity is compromised.
Results
YPK9 cells depend on LAG1 and LAC1 to make the
bulk of sphingolipids
When YPK9 lag1D lac1D (2D.LAG1) cells containing a
plasmid-born copy of LAG1 behind the GAL1 promoter
were very strongly depleted of Lag1p on glucose and
were then labelled with [3H]inositol, they made no normal
sphingolipids anymore (Fig. 2, lane 8), but they incorpo-
rated as much [3H]inositol into lipids as when growing on
galactose (Fig. 2, lanes 2 and 4). After depletion, the only
mild base-resistant lipid still made was the uncharacter-
ized ‘lipid a’ (Fig. 2, lane 8), but cells had stalled all syn-
thesis of normal IPCs, MIPCs and lipid b that one ﬁnds in
W303 lag1D lac1D cells (Guillas et al., 2001). Thus, unlike
W303 lag1D lac1D, the YPK9 lag1D lac1D background did
not seem to contain any alternative pathways or enough
endogenous Ypc1p and Ydc1p activity for making ceram-
ides and mild base-resistant inositolphosphorylsphin-
goids, as is further detailed in Supporting information.
Overexpression of YDC1 in YPK9 lag1D lac1D allows
for the synthesis of small amounts of IPCs
YPK9 lag1D lac1D cells are not viable but the strain can
be rescued by overexpression of YDC1 and the thus
Fig. 1. Major pathways of sphingolipid biosynthesis in yeast.
Gene names are in italic and enzyme inhibitors in bold italics. Note
that Ypc1p utilizes all long-chain bases (LCBs) whereas Ydc1p only
utilizes DHS (Mao et al., 2000b). PI, phosphatidylinositol; DAG,
diacylglycerol; GDP-Man, GDP-mannose.
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rescued strain (2D.YDC1) grows, albeit at a reduced
rate, as described (Jiang et al., 2004). The proﬁle of
[3H]inositol-labelled lipids of 2D.YDC1 is shown in
Fig. 3A. It appears that the cells not only make ‘lipid a’,
but also some mild base-resistant species co-migrating
with IPC-3, IPC-4 and IPC-5, suggesting that Ydc1p can
act as a ceramide synthase in vivo. Yet, the quantiﬁca-
tion of this radiogram showed that 2D.YDC1 made about
11 times less sphingolipids than wt (Table S1). When
2D.YDC1 cells were labelled with [3H]DHS, they made
several mild base, i.e. monomethylamine (MMA)-
resistant lipids (Fig. 3B, lanes 3 and 4, bracketed), which
were less hydrophobic than the normal PHS-C26:0-OH
of wt cells (Fig. 3B, lane 2). These potential ceramides
have not been further characterized but the ESI-MS
analysis of IPCs suggests that they are ceramides con-
taining fatty acids with less than 26 C atoms (see
below).
In vitro ceramide synthase activity (reverse cerami-
dase activity) of Ydc1p was only detectable with DHS,
but not with PHS as a substrate (Mao et al., 2000b).
Because DHS is continuously transformed into PHS by
Fig. 2. Sphingolipid proﬁle of 2D.LAG1 after strong depletion of
Lag1p. 2D.LAG1, a strain harbouring LAG1 behind the GAL1
promoter, was depleted of Lag1p by pre-culture on glucose (Glc,
SDaaA) for 30 h or left on galactose (Gal, SGaaA). YPK9 (WT)
cells were also cultured in either SGaaA or SDaaA for 15 h before
labelling, all pre-cultures being performed in media without inositol.
Aliquots of 2.5 A600 units of cells were labelled with [3H]inositol at
30°C for 2 h in the same type of media as used in the pre-culture.
The lipids were extracted, desalted and treated with
monomethylamine (+MMA, lanes 5–8) to remove
glycerophospholipids or were mock incubated (-MMA, lanes 1–4).
Then they were analysed by TLC using solvent system 3. The total
incorporation of [3H]inositol into lipids is given as a fraction (%) of
the total radioactivity added to cells below lanes 1–4. IPC-3, -4, -5
containing ceramide moieties with three, four or ﬁve hydroxyl
groups (sum of hydroxyls on LCB and the fatty acid) correspond to
IPC/B, IPC/C and IPC/D respectively (Haak et al., 1997). M(IP)2C
and glycerolphosphorylinositol stay at the origin in this TLC system.
Fig. 3. Overexpression of YDC1 in YPK9 lag1D lac1D strains fails
to restore a normal ceramide and sphingolipid proﬁle.
A and B. Five A600 units of 2D.YDC1, 2D.LAG1 and YPK9 (WT)
cells were grown on SDaaA without inositol and labelled with
[3H]inositol (A) or [3H]DHS (B) in the same way as described in
Fig. 2. [3H]inositol labelling of 2D.YDC1 and YPK9 was stopped
after 0.3 generation times, which corresponded to 2.3 and 1 h of
labelling, respectively, in order to compensate for the slower growth
of 2D.YDC1. Lipids were extracted, desalted, deacylated or not with
monomethylamine (MMA) and run on TLC using solvent system 3
(A) or 1 (B). The bracket next to lane 3 of (B) indicates abnormal
base-resistant lipids. The ﬁgures show one of two experiments,
which gave identical results.
C. The indicated strains were pre-cultured in SDaaUA and inositol
was removed during last hour of pre-culture. Cells were then
labelled with [3H]inositol and lipids were extracted. Aliquots of
extract corresponding to 106 c.p.m. were deacylated with NaOH or
control incubated; desalted lipids were separated by TLC in solvent
system 2. Figures below the lanes indicate the amount of mild
base-resistant lipids as a percentage of the total of labelled lipids in
each lipid extract, determined by radioscanning.
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Sur2p (Fig. 1), we ﬁgured that the DHS concentration in
2D.YDC1 may be too low to allow the DG′ for ceramide
synthesis by Ydc1p to become negative. We therefore
deleted SUR2 in 2D.YDC1, thus generating the YPK9
lag1D lac1D sur2D strain named 3D.YDC1. As shown in
Fig. 3C and in a second identical experiment (Fig. S1),
labelling with [3H]inositol and mild base deacylation
revealed that deletion of SUR2 in 2D.YDC1 increased
the amount of sphingolipids 1.5-fold, but did not change
the thin-layer chromatography (TLC) migration of the
main species (Fig. 3C, lanes 3–6). Indeed, 2D.YDC1 and
3D.YDC1 showed a rather similar sphingolipid proﬁle on
TLC (Fig. 3C, lanes 4 and 6), which was different from
the one of YPK9 (Fig. 3C, lane 2; Fig. S1). (It should be
noted that the TLC system used is more sensitive
towards the number of hydroxyls than to the length of
the fatty acids.)
Mass spectrometric analysis of IPCs generated by
Ydc1p in vivo
To further characterize the sphingolipid proﬁle of 2D.YDC1
and 3D.YDC1, their lipid extracts were analysed by mass
spectrometry (HPLC-ESI-MS/MS) in the negative ion
mode. As shown in Fig. 4A, YPK9 cells only make IPCs
with 42, 44 or 46 C atoms and mostly three, four or ﬁve
hydroxyl groups in their ceramide moiety. (DHS and PHS
are counted as contributing two and three hydroxyls,
respectively, the remaining hydroxyl groups being
attached to the fatty acid moiety). Since most yeast sph-
ingolipids contain long-chain bases (LCBs) with 18, less
frequently 20 C atoms, it is likely that the main IPCs of
YPK9 wt cells (IPC44-3, 44-4 and 44-5) contain C26 and
C24 fatty acids and their mono- and dihydroxylated
derivatives. Indeed, already the ﬁrst studies by Robert
Fig. 4. HPLC-ESI-MS/MS analysis of
sphingolipids of 2D.YDC1 and 3D.YDC1.
Lipids were extracted quantitatively (Hanson
and Lester, 1980) from cells growing
exponentially in YPD at 30°C; lipids were
deacylated with mild base, and analysed by
HPLC-ESI-MS/MS. Parent ion and fragment
ion masses (m/z) were recorded throughout
the HPLC run and were screened for all
theoretically possible sphingolipids containing
different saturated, monounsaturated, and
non-, mono- or dihydroxylated fatty acids
combined with DHS or PHS as well as for
conventional phospholipids. Sphingolipids are
speciﬁed by two consecutive numbers
standing for the number of C atoms and
hydroxyls in their ceramide moiety
respectively. The masses corresponding to
these abbreviations are indicated in Table S2.
The vertical axis indicates the ion counts. All
species were identiﬁed as phosphoinositides
by characteristic fragment ions at m/z 259
and 241, corresponding to inositolphosphate
and [inositolphosphate-H2O] except when ion
counts were <2000. The x-axis only lists
those species that indeed were found to be
present in at least one of the analysed
strains. Before injection, the lipid extracts
were mixed with a ﬁxed amount of lipid
extract from wt cells grown in [13C]glucose as
the only carbon source and the data were
normalized using this internal standard. Note
that intensities of DHS- and PHS-containing
sphingolipids are not directly comparable
since they ionize with different efficiency.
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Lester showed that the most frequent IPC of yeast con-
tains a PHS with 18 C atoms and a monohydroxylated
C26 fatty acid, which translates into a 44-4 species (Smith
and Lester, 1974). The species with 46 C atoms may
contain a LCB with 20 C atoms or a fatty acid with 28 C
atoms. [In other strains it was observed that 2% of LCBs
contain 20 C atoms (Smith and Lester, 1974) and 2% of
very long-chain fatty acids are C28 (Oh et al., 1997).]
Overall, the proﬁle of sphingolipids of our YPK9 cells is
very similar to the one recently published for another
yeast wt strain, RH690-15D, except that this latter con-
tains more IPC46-4 than IPC44-5 (Ejsing et al., 2006).
The proﬁle of YPK9 is also very comparable to the one of
BY4741 (Guan and Wenk, 2006).
Quite differently from YPK9, 2D.YDC1 cells contain
similar amounts of IPCs with 36, 38, 40, 42, 44 and 46
C atoms in their ceramide moiety, suggesting that the
fatty acids C18, C20, C22, C24 and C26 all are used
with even frequency (Fig. 4A). Data further show that
most IPCs of 2D.YDC1 have only two or three hydroxyls
in their ceramide moiety and that the proﬁle of 3D.YDC1
is almost the same as the one of 2D.YDC1, except for
the lack of some minor IPC44-4 and IPC44-5 species. It
should be noted that 3D.YDC1 cells cannot make PHS,
but only DHS, so that all species containing three
hydroxyls by necessity contain a monohydroxylated fatty
acid linked to DHS. Since 2D.YDC1 have almost the
same IPC proﬁle as 3D.YDC1, we have to conclude that
in vivo Ydc1p exclusively makes DHS-containing cera-
mides even in the 2D.YDC1 strain, in which PHS is quite
abundant (Table 1).
As a control we used a YPK9 lag1D strain overexpress-
ing YPC1 (1D.YPC1) from a LEU2 multicopy vector of the
same type as present in 2D.YDC1 and 3D.YDC1. Figure 4
shows that its sphingolipid proﬁle is very similar to the one
of YPK9, indicating that neither the presence of a LEU2
vector nor the overexpression of a ceramidase/reverse
ceramidase by itself has an impact on the sphingolipid
proﬁle in a strain still possessing an acyl-CoA-dependent
ceramide synthase.
Low amounts of IPCs with a double bond in their cera-
mide moiety were found in all cell lines (not shown). It has
been known for a long time that a small fraction of yeast
sphingolipids contains an LCB with a double bond (Smith
and Lester, 1974), whereas unsaturated C24 and C26 are
undetectable (Ejsing et al., 2006; Guan and Wenk, 2006)
or very scarce (Oh et al., 1997).
MIPCs of all cells contained the same number of
hydroxyls as present in ceramides of their IPCs (except
that there is no 46-5 MIPC) (Fig. 4B). In contrast, in all
strains, the ceramides of MIPCs mostly had C24 or C26
fatty acids and IPCs with shorter fatty acids, very preva-
lent in 2D.YDC1 and 3D.YDC1, were not efficiently utilized
for MIPC synthesis (Fig. 4B). Data also show that the
ceramides of M(IP)2Cs are very similar to the ones of
MIPCs in almost all cells, except that cells rarely make
M(IP)2Cs from MIPC 44-5 (Fig. 4B versus Fig. 4C). Curi-
ously, M(IP)2C levels were much higher in 2D.YDC1 and
3D.YDC1 than in wt cells (Fig. 4C).
Mass spectrometry also showed that 2D.YDC1 had two
times higher amounts of phosphatidylinositol (PI), in
accordance with the slower IPC biosynthesis observed in
metabolic labelling experiments (Fig. 3C, Fig. S1).
Mass spectrometric analysis indicates the presence of
C26:0 in phosphatidylinositol of 2D.YDC1
2D.YDC1 cells harbour abnormally high amounts of PI′
(Fig. 3A, lane 2 versus 1, and Table S1; Fig. 3C, lane 3
versus 1). PI′ is characteristic for 2D cells and was pro-
posed to represent a hydrophobic PI species containing
C26:0 fatty acids instead of the normal C16 and C18
species (Guillas et al., 2001; Cerantola et al., 2007).
This is conﬁrmed in our MS analysis of 2D.YDC1 by the
presence of strong m/z signals at 947.7 and 975.8,
signals that were not seen in wt. These signals corre-
spond to PI species with a total of 42 or 44 C atoms and
one double bond in their two fatty acids (PI 42:1 and PI
44:1) respectively. Fragmentation of the 975 parent ion
yielded fragment m/z signals at 281, 395, 579, 693 and
711, corresponding to [M-H] masses of C18:1, C26:0,
[lyso-PI(C18:1)-H2O], [lyso-PI(C26:0)-H2O] and lyso-
PI(C26:0), respectively, conﬁrming the identity of 975.7
as PI with a C26:0 and C18:1 fatty acid, the latter pre-
sumably residing in sn-2. This type of lipid is also
observed in low amounts in normal cells (Schneiter
et al., 2004). The high levels of PI′ in 2D.YDC1 suggest
that C26:0-CoA or C26:0 levels are abnormally high in
this strain. Higher than normal levels of C26:0 are prob-
ably necessary in order to generate a negative DG′ for
ceramide synthesis by Ydc1p. As reported before for
other strains (Schneiter et al., 2004; Cerantola et al.,
2007), C26:0-containing species were found only in PI
but no other glycerophospholipid species.
Table 1. Accumulation of free long-chain bases in lag1D lac1D cells.
PHS DHS
Fold
increase
YPK9 7.5  3.6 10.2  7.2 1
2D.LAG1a 364.1  175.5 98.7  53.7 26
1D.YPC1 57.3  37.6 22.8  22.3 4.5
2D.YDC1 387.5  150.2 254.4  149.5 36
a. The data on 2D.LAG1 are from cells grown on glucose.
Numbers indicate pmoles per A600 unit of cells. Results are the mean
of three experiments and ﬁve different determinations. The last
column compares the sum of PHS and DHS with the normal levels set
to 1.
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2D.YDC1 and 3D.YDC1 cells are relatively resistant to
stresses known to block growth of sphingolipid-deﬁcient
cells
The robustness of 2D.YDC1 and 3D.YDC1 strains with
regard to stress conditions known to block the growth of
cells having an abnormal sphingolipid biosynthesis was
tested as detailed in Figs S2 and S3. We found that
neither the 2D.YDC1 nor the 3D.YDC1 strain was sen-
sitive to temperature (Fig. S2) or low pH (not shown).
Moreover, 3D.YDC1 showed similar resistance to most
stress conditions as parental YPK9 cells. 2D.YDC1 cells
grew slightly less well than 3D.YDC1 and YPK9 already
in the absence of any stress, and their growth was also
weaker in most stress conditions. However, 2D.YDC1
cells gained almost normal growth at all temperatures
between 17°C and 37°C on a specially designed
medium containing high concentrations of amino acids
and inositol, here termed Lester medium (LM) (Pinto
et al., 1992) (Fig. 5A and data not shown). LM also
restored better growth on glucose to 2D.LAG1 (Fig. 5A).
Metabolic labelling experiments demonstrated that LM
Fig. 5. Aureobasidin A (AbA) resistance of various lag1D lac1D strains. Aliquots of cell suspensions having an A600 of 10 and 10-fold serial
dilutions thereof were plated on various media in (A), and on Lester medium (LM) in all other panels.
A. Cells were plated on SDaaUA medium without inositol (SD) or with inositol (2 mg ml-1; SD+Ino), or on LM in the presence or absence of
AbA. Plates were incubated at 24°C for 4 days.
B. Strains were plated with or without AbA (0.25 mg ml-1) and incubated for 5 days at 24°C or 37°C. (Two different subclones of W303 lag1D
lac1D were tested.)
C. Cells were plated in the presence or absence of 2.5 mg ml-1 AbA and incubated for 5 days.
D. Cells having been growing on 0.25 mg ml-1 AbA were scraped from the plate shown in (B) (boxed), were counted and replated on the same
medium or on LM and incubated at 24°C for 4 days. For some cells the A600 value of the starting cell suspension was less than 10 as
indicated.
E. Cells having been replated on AbA (boxed in D) were counted and replated on LM plates with various concentrations of AbA (0, 0.25 and
2.5 mg ml-1) and incubated for 5 days at 24°C.
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increased the capacity of 2D.YDC1 to make IPCs
(Fig. 6, lane 4 versus 2). Yet, 2D.LAG1 cells could not
loose pBM150-LAG1 on SDaaUA in the presence of
5′-ﬂuoroorotic acid and high concentrations of inositol,
even in the presence of 10% glycerol, which can act as
a chemical chaperon (not shown). On the contrary, omis-
sion of inositol from synthetic medium (SD) diminished
the growth rate of 2D.LAG1 and 2D.YDC1, while growth
of 1D.YPC1 was independent of exogenous inositol
(Fig. 5A).
Additional experiments showed that the notable cell
wall thickening of lac1D lag1D cells described by Barz and
Walter (1999) was not corrected in 2D.YDC1 (Fig. S4E
and F versus Fig. S4C and D).
Lac1D lag1D cells cannot grow on AbA for
prolonged periods
W303 lag1D lac1D and W303 lag1D lac1D ypc1D ydc1D
grew reasonably well in the presence of high concentra-
tions of AbA, an inhibitor of the IPC synthase AUR1
(Nagiec et al., 1997; Schorling et al., 2001; Vallée and
Riezman, 2005). As shown in Fig. 5A, right panels, when
placed on LM or inositol-containing SDaaUA medium,
those YPK9 cells having difficulty in making ceramide
(2D.LAG1) or those making ceramide through reverse
ceramidase activity (2D.YDC1) were relatively resistant to
AbA. In contrast, wt YPK9 and 1D.YPC1 cells, making
sphingolipids using an acyl-CoA-dependent ceramide
synthase, were sensitive. To exclude the possibility that
2D.YDC1 cells did not take up AbA efficiently, we evalu-
ated the effect of AbA on the incorporation of [3H]inositol
into sphingolipids. As can be seen in Fig. 6, biosynthesis
of IPCs in 2D.YDC1 and 2D.LAG1 cells was completely
inhibited by AbA (Fig. 6, lanes 2, 4, 6, 8 versus 3, 5, 7, 9).
This argues that the uptake of AbA in 2D.YDC1 and
2D.LAG1 strains is normal. Further studies however
revealed that the AbA resistance of 2D.YDC1 and
2D.LAG1 is only relative. (i) Temperature appeared to be
critical as 2D.LAG1 cells grew only poorly in the presence
of AbA (0.25 mg ml-1) at 30°C or 37°C (not shown). (ii)
Other tests also showed that 2D.YDC1 were not resistant
to very high concentrations of AbA (2.5 mg ml-1, Fig. 5C)
and that the cells growing on plates containing
0.25 mg ml-1 AbA were not able to further grow when
inoculated a second time on 0.25 mg ml-1 AbA (Fig. 5D
and not shown). Thus, AbA resistance of 2D.YDC1 cells
was only relative, not absolute.
We wondered if the same is true for W303 lag1D lac1D
(2D.W303) and W303 lag1D lac1D ypc1D ydc1D (4D.
W303) cells. As can be seen on Fig. 5B, at 24°C the
2D.W303 cells were much more resistant to 0.25 mg ml-1
AbA than the parental W303 wt strain, and 4D.W303,
growing less well than 2D.W303, nevertheless grew as
well on AbA as in its absence, albeit only at high cell
density. At 37°C, without AbA, 2D.W303 and 4D.W303
grew almost as well as at 24°C, but their growth was more
reduced in the presence of AbA than at 24°C. When
higher concentrations of AbA were used (2.5 mg ml-1),
2D.W303 and 4D.W303 still grew but 2D.W303 grew less
than on 0.25 mg ml-1 AbA (Fig. 5C). When we tried to
propagate 2D.W303 and 4D.W303 cells having grown on
0.25 mg ml-1 AbA at 24°C by replating them onto the same
medium and incubating them at 24°C, they grew less well
than when they had been put onto 0.25 mg ml-1 AbA for
the ﬁrst time, although they grew very well in the absence
of AbA (Fig. 5D). Replating 2D.W303 and 4D.W303 cells
a third time on AbA demonstrated that cells continued
to survive on 0.25 mg ml-1 but did not grow at all on
Fig. 6. Aureobasidin A (AbA) efficiently abolishes IPC synthesis in
lag1D lac1D cells. 2D.YDC1 and 2D.LAG1 cells were grown for 16 h
in minimal medium (M, SDaaA without inositol) or LM, leading to
partial depletion of Lag1p in 2D.LAG1. Four hours before adding
radioactivity all cells were transferred to SDaaA lacking inositol to
induce the inositol transporter Itr1p. Cells were labelled with
[3H]inositol in SDaaA, in the presence or absence of AbA
(2 mg ml-1); lipids were extracted, treated (bottom) or not (top) with
monomethylamine (MMA) and separated by TLC in solvent 3.
Deacylation was incomplete in this experiment, as some lyso-PI
was left after deacylation, but this material was no more present
after deacylation using methanolic 0.1 M NaOH at 37°C for 1 h (not
shown). The experiment also shows that pre-culture in LM
stimulated the incorporation of [3H]inositol into 2D.YDC1, a ﬁnding
that may explain the positive effect of LM on cell growth.
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2.5 mg ml-1 AbA (Fig. 5E). Thus, 2D.W303 and 4D.W303
are more resistant against AbA but they cannot be grown
for prolonged periods on very high concentrations of AbA.
AbA does not cause the accumulation of ceramides in
2D.YDC1 cells
To understand if 2D.YDC1 stopped growing in the pres-
ence of AbA because of the accumulation of toxic levels of
ceramides or for lack of IPCs, we measured ceramide
levels in cells incubated with AbA at 30°C. In the experi-
ment shown in Fig. 7A and B, the ceramides increased
signiﬁcantly during incubation with AbA in all strains, while
during the same time IPC levels decreased (3.4- and
3-fold in YPK9 and 2D.YDC1, respectively, not shown).
Importantly, ceramides were below the detection limit in
2D.YDC1 in the absence of AbA, i.e. the strain had at least
530 times less ceramide 44-4-0 than wt cells. Even when
treated with AbA, the most prominent species appearing,
44-4-0, remained ﬁve times lower than the one of
untreated wt cells (Fig. 7A and B). This probably reﬂects
the fact that ceramide synthesis in 2D.YDC1 ceases as
soon as ceramide concentrations reach a level, at which
the free energy change (DG′) for ceramide synthesis
by a reverse ceramidase activity becomes zero [DG′ =
DG°′ + RT·ln([ceramide]/[fatty acids]·[DHS])]. In contrast,
the DG°′ for the hydrolysis of acyl-CoAs is in the order of
-35 kJ mol-1, and in wt cells this energy is utilized by the
acyl-CoA-dependent ceramide synthases Lag1p and
Lac1p so that the DG′ of ceramide synthesis remains
negative even when ceramide reaches very high
concentrations. The very low ceramide levels in AbA-
treated 2D.YDC1 cells strongly argue that these cells do
not die from accumulating ceramides but rather from the
absence of IPCs.
The lipid proﬁles also revealed that cells contained
signiﬁcant amounts of C26:0-OH (Fig. 7C). As Scs7p
(Fig. 1), the a-hydroxylase for C26:0 fatty acids, is
believed to utilize as substrates only ceramides or IPCs
(Haak et al., 1997), the free C26:0-OH fatty acids must be
breakdown products and this suggests that part of sphin-
golipids is continually hydrolysed even in the absence of
AbA.
Curiously, titration of AbA showed that the 2D.YDC1 and
3D.YDC1 cells were more sensitive than wt at low con-
centrations of AbA (0.03 mg ml-1) although they resisted
AbA better than wt at high concentrations (0.3 mg ml-1)
(Fig. 8). We interpret these data in the sense that IPCs are
essential for yeast cells and that, because of a less effi-
cient ceramide and IPC biosynthesis, IPC levels become
Fig. 7. Ceramide levels in 2D.YDC1. Lipids were extracted from
cells having been growing exponentially in YPD at 30°C, and grown
further either in the presence or in the absence of 0.25 mg ml-1 AbA
during 4 h at 30°C. Extracts were mixed with internal 13C standard,
deacylated and analysed by HPLC-ESI-MS/MS as in Fig. 4.
Negative ions were scanned and screened for all theoretically
possible ceramide species containing different saturated,
monounsaturated, and non-, mono- or dihydroxylated fatty acids
combined with DHS or PHS.
A and B. Ceramides shown in (A) and (B) are qualiﬁed by three
numbers indicating the number of C atoms, double bonds and
hydroxyls. (B) Some extracts were re-run using a HPLC program
favouring detection of ceramides.
C. C26:0-OH levels (m/z = 411) of same cell extracts are depicted.
In (A) and (B) the x-axis only lists those ceramide species, which
indeed were found to be present in at least one of the analysed
strains. The vertical axis in all panels indicates ion counts ¥ 10-3
per A600 unit of cells.
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subcritical in 2D.YDC1 and 3D.YDC1 already at
0.03 mg ml-1 AbA, concentration at which wt cells continue
to grow. At higher concentrations (0.3 mg ml-1) of AbA
however, wt cells acutely stop cell growth because of
ceramide accumulation and this latter phenomenon does
not occur in 2D.YDC1 and 3D.YDC1 cells (Figs 5A, 7 and
8). After prolonged growth at this concentration however,
also 2D.YDC1 cells cease to grow because synthesis of
IPCs is blocked or becomes limiting (Fig. 5D).
Synthesis of abnormal inositolphosphorylsphingoids in
4D.W303 is blocked by AbA
Metabolic labelling of 4D.W303 in the absence or pres-
ence of AbAwith [3H]inositol demonstrated that these cells
still make mild base-resistant inositolphosphorylsphin-
goids, and this in spite of the absence of all known
enzymes catalysing ceramide synthesis (Fig. 9A, lane 3
versus 1). Some of this material migrates in the region of
IPC-4 and IPC-5, whereas several more abundant and
more polar lipids migrate between MIPC and M(IP)2C
(Fig. 9A, lanes 3 and 7 versus 1). In two different solvent
systems it appears that there are at least ﬁve different
mild base-resistant lipids made in 4D.W303 (Fig. 9A,
lanes 3 and 7; Fig. 9B, lanes 2 and 6). Importantly, the
synthesis of these abnormal inositolphosphorylsphingoids
is inhibited by AbA (Fig. 9A, lanes 5 and 9 versus 3 and 7;
Fig. 9B, lanes 4 and 8 versus 2 and 6). This suggests that
the growth of 4D.W303 is blocked by AbA (Fig. 5E) since
the drug blocks the biosynthesis of essential inositolphos-
phorylsphingoids which can functionally replace IPCs.
The biosynthetic pathway for generation of these various
abnormal sphingolipids apparently only exists in the
genetic background of W303, not in the one of YPK9
(Fig. 9, lanes 3 and 7 versus Fig. 2, lane 8).
Accumulation of LCBs is not toxic but rather essential
for growth of 2D.YDC1 cells
The accumulation of endogenous LCBs or the addition of
exogenous LCBs to the growth medium has been
reported to be toxic for certain strains, whereby PHS is
Fig. 8. 2D.YDC1 and 3D.YDC1 cells are hypersensitive to
Aureobasidin A (AbA). Tenfold serial dilutions of indicated strains
were plated on YPDUA plates containing various concentrations of
AbA and incubated for 3 days at 24°C.
Fig. 9. Synthesis of abnormal inositolphosphorylsphingoids in
4D.W303 is blocked by Aureobasidin A (AbA).
A. Wild-type (lane 1) or 4D.W303 cells (lanes 2–9) were grown in
Lester medium (lanes 2–5) or LM adjusted to pH 6.75 with
3-(N-Morpholino)-propanesulphonic acid (MOPS) (lanes 6–9), and
labelled with [3H]inositol in inositol-free LM for 4 h at 30°C, either in
the presence or in the absence of AbA (2.5 mg ml-1). [Medium with
pH 6.75 was utilized because of the difficulty of sphingolipid-
deﬁcient strains to maintain the cytosolic pH in acidic media (Patton
et al., 1992).] Lipids were extracted, deacylated with NaOH or mock
incubated, desalted and analysed by TLC in solvent system 2,
radioscanning and ﬂuorography. Figures indicate the amount of
base-resistant lipids present after NaOH treatment as percentage
of the total c.p.m. present in the not deacylated lipid extract. For
comparison, when parental W303 cells were labelled under
identical conditions, 68% of radioactivity was in mild base-resistant
lipids (not shown).
B. As (A), but TLC separation was performed in solvent system 3.
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more toxic than DHS (Mao et al., 2000b; Chung et al.,
2001). Possible reasons may be that PHS causes the
inhibition or degradation of essential nutrient transporters
(Skrzypek et al., 1998; Chung et al., 2000; 2001), or that
PHS compromises glucan biosynthesis (Abe et al., 2001).
As shown in Table 1, 2D.YDC1 cells have very high levels
of LCBs, levels that are in the same range as those
reported for W303 lag1D lac1D cells (Guillas et al., 2001).
To address the question as to whether the high concen-
trations of PHS in 2D.YDC1 (Table 1) may contribute to
the slower growth of these cells, we tested if the growth of
2D.YDC1 could be improved by partial inhibition of LCB
biosynthesis in the presence of myriocin (Fig. 1). As seen
in Fig. 10, myriocin did not improve the growth of
2D.YDC1 cells, quite to the contrary: 2D.YDC1 cells were
extremely hypersensitive to myriocin and even 3D.YDC1
were hypersensitive. A likely explanation is that the very
high levels of DHS in those cells are required in order to
grant a negative DG′ for reverse ceramidase, i.e. ceram-
ide synthesis by Ydc1p, and that any reduction of ceram-
ide and therefore IPC biosynthesis causes IPC levels to
become subcritical. Furthermore, YPK9, 2D.YDC1 and
3D.YDC1 cells were completely resistant to 25 mM DHS
(Fig. S5, top) or 25 mM PHS (not shown), which ought to
further elevate LCB levels in the cells.
A recent study demonstrates that exogenous and
endogenous LCBs form functionally different intracellular
pools (Brace et al., 2007). To see whether exogenous
LCBs can access Ydc1p for formation of sphingolipids,
we tested whether 2D.YDC1 can survive on exogenous
LCBs when endogenous LCB biosynthesis is blocked by
myriocin. Addition of exogenous DHS could only partially
compensate the myriocin hypersensitivity of 2D.YDC1
and 3D.YDC1 cells (Fig. S5), i.e. only at very low concen-
trations of myriocin (0.1 mg ml-1). One explanation is to
assume that the uptake mechanism cannot concentrate
DHS sufficiently to force reverse ceramidase activity, at
least not in the pool of LCBs, which is accessible for
Ydc1p. Yet, at higher concentrations of myriocin, also wt
cells died, possibly because of the same insufficiency of
LCB uptake or because of non-speciﬁc toxicity of the
drug.
Discussion
Before its target was known, it was established that AbAat
high concentrations kills 99% of wt yeast cells within 1 h
of exposure (Endo et al., 1997), but subsequent studies
showed that lag1D lac1D cells can grow in the presence of
AbA and proposed that IPCs may not be required for the
growth of yeast cells (Schorling et al., 2001; Vallée and
Riezman, 2005). Our data conﬁrm, using newly made
strains, this previously reported AbA resistance of W303
lag1D lac1D and W303 lag1D lac1D ypc1D ydc1D cells
at 24°C and show that high concentrations of AbA
(0.3 mg ml-1) also are not immediately arresting the growth
at 24°C of lag1D lac1D double mutants in the more sen-
sitive YPK9 background. These previous and our present
ﬁndings are most reasonably explained by assuming
that high ceramide levels cause a rapid growth arrest
in wt cells containing acyl-CoA-dependent ceramide
synthases. Yet, our results now indicate that prolonged
exposure to AbA or exposure to higher concentrations of
AbA stops the growth of cells of all genetic backgrounds,
even those that lack acyl-CoA-dependent ceramide syn-
thases and therefore do not accumulate ceramides in the
presence of AbA (Figs 5B–E and 6A). Moreover, in the
presence of AbA, 2D.YDC1 cells abruptly stop the biosyn-
thesis of IPCs (Fig. 6), while their ceramide levels remain
very low (Fig. 7A). These data argue therefore that AbA
deprives 2D.YDC1 cells of IPCs and clearly points to the
importance of IPCs for the survival of YPK9 cells. Data
further suggest that this essential role of IPCs can be
Fig. 10. 2D.YDC1 and 3D.YDC1 cells are hypersensitive to
myriocin. Tenfold dilutions of the various strains were deposited
onto plates containing between 0 and 0.32 mg ml-1 myriocin (myr)
plus 0.5% CH3OH. Plates were incubated at 30°C for 3 days.
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taken over by anomalous inositolphosphorylsphingoids,
which also seem to be made by an AUR1-dependent
pathway (Fig. 9). On the other hand, the ceramide levels
of 3D.YDC1 cells are extremely low, and yet, the cells
show normal growth and stress resistance; this argues
that ceramides are probably not required as signalling
molecules during the stresses tested. Interestingly, a
series of seminal studies performed 15 years ago led to
a similar conclusion, namely that yet another kind of
anomalous lipids can take over the role of sphingolipids.
These reports showed that sphingolipids are altogether
dispensable for certain yeast cells harbouring a gain of
function suppressor allele in the lyso-phosphatidate acyl-
transferase SLC1 (Nagiec et al., 1993). The SLC1-1 allele
allows lcb1D cells to synthesize PI with a C26 fatty acid at
the sn-2 position of the glycerol moiety, a form of PI that
subsequently can be mannosylated in the same way as
IPCs, whereas PI of wt cells does not get mannosylated
(Fig. 1) (Lester et al., 1993). It is very likely that this C26-
containing form of PI can functionally replace IPCs in their
essential roles.
It may be hypothesized that the high concentrations of
AbA required to stop the growth of 2D.W303 and 4D.W303
cells (2.5 mg ml-1) are exerting non-speciﬁc toxic effects.
While theoretically possible, this seems to be rather
unlikely because various single-point mutations in AUR1
were reported to make wt cells resistant to very high
concentrations (> 20 or 25 mg ml-1) of AbA, i.e. 100- to
500-fold more resistant than wt cells, and this without
affecting their sensitivity to other drugs (Heidler and
Radding, 1995; Hashida-Okado et al., 1996).
Acute AbA intoxication leads to a defect in bud growth
and release of vacuolar and cytosolic amino acids into the
medium indicating a loss of the vacuolar and plasma
membrane barriers, a loss that cannot be relieved by
osmotic support (Endo et al., 1997). Thus, IPCs or IPC-
like sphingolipids may just be required for adequate
membrane structure, but they may also have more spe-
ciﬁc roles in GPI protein and membrane protein transport
(Watanabe et al., 2002; Gaigg et al., 2005; 2006) and
stabilization of membrane channels (Lee et al., 2002;
Chung et al., 2003). Depletion of Aur1p also leads to the
disappearance of microtubuli and of tubulin, but it is not
clear if this is due to an increase of ceramide or a
decrease of IPCs (Hashida-Okado et al., 1996).
YPC1 and YDC1 were originally identiﬁed in a screen
for multicopy suppressors of the growth inhibition caused
by the lack of acyl-CoA-dependent ceramide synthase
activity, and were readily recognized as genes respon-
sible for an alternative, acyl-CoA-independent ceramide
biosynthesis pathway (Mao et al., 2000a,b) (Fig. 1). The
present study further characterizes the enzymatic poten-
tial of Ydc1p in the YPK9 genetic background where the
acyl-CoA-dependent ceramide synthesis was genetically
inactivated and no alternative sphingolipid biosynthesis
pathways are operating (Fig. 2). In this context our data
ﬁrst demonstrate that Ydc1p can efficiently synthesize
ceramides in vivo. Indeed, it has previously been
assumed that Ydc1p has little reverse ceramidase activity.
This assumption was based on its low reverse cerami-
dase activity in vitro as measured with [3H]C16:0 as a
substrate (Mao et al., 2000b), on the fact that only YPC1
but not YDC1 was isolated in two independent screens for
high-copy suppressors of a lag1D lac1D growth defect
(Schorling et al., 2001; Jiang et al., 2004) and from the
comparison of the growth behaviour of YPC1- versus
YDC1-complemented lag1D lac1D strains. Data shown
here demonstrate that Ydc1p can produce signiﬁcant
amounts of sphingolipids in vivo and can, when overex-
pressed, restore a normal growth and stress resistance to
3D.YDC1 cells. Moreover, data in Figs 3 and 4 document
that in vivo Ydc1p utilizes only DHS, not PHS, as was
found in vitro (Mao et al., 2000b). Furthermore, Ydc1p can
use fatty acids of any length between C18 and C26 with
similar efficiency. It is noteworthy that the various ceram-
ides of 2D.YDC1 cells comprise the major ceramide
species encountered in mammalian cells so that 2D.YDC1
cells, by offering appropriate ceramide substrates, may be
a suitable host for the functional expression of mamma-
lian sphingolipid-synthesizing enzymes.
Data shown in Fig. 5A indicate that the reported rela-
tive inositol auxotrophy of lcb1D SLC1-1 lacking all LCBs
is also present in strains which have a deﬁciency in
ceramide biosynthesis (2D.YDC1 and glucose-grown
2D.LAG1) and which therefore contain very high concen-
trations of LCBs. Thus it would appear that inositol is not
required to compensate for the lack of PHS-mediated
signalling through the Pkh1p/Pkh2p signalling pathway
(Dickson et al., 2006) or for the lack of signalling through
PHS-1-phosphate, but for some other function. Removal
of inositol from the growth medium is known to upregu-
late the unfolded protein response (UPR) (Cox et al.,
1997) and to inactivate Opi1p, a transcriptional repres-
sor for numerous genes involved in lipid biosynthesis
(Loewen et al., 2004). A UPR response, caused by the
lack of inositol in the medium, may be harmful in a situ-
ation where sphingolipid biosynthesis is restricted. In
contrast, addition of inositol to the growth medium down-
regulates the UPR and strongly increases PI biosynthe-
sis (Gaspar et al., 2006), not only by providing more
substrate for the PI synthase Pis1p, but possibly also by
downregulating PSD1 and OPI3, which draw, as Pis1p,
on the primal substrate CDP-diacylglycerol (Santiago
and Mamoun, 2003). Addition of inositol to the growth
medium has also been reported to increase the IPC syn-
thase activity twofold (Ko et al., 1994). The increased
biosynthesis of PI, the substrate of Aur1p (Fig. 1) and
the increased Aur1p activity may thus stimulate IPC
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biosynthesis and thereby increase the robustness of
2D.YDC1 cells.
Our studies also shed some light on the potential physi-
ological roles of YPC1 and YDC1. Although their physi-
ological expression levels are too low as to allow cell
survival of YPK9 lag1D lac1D cells, they markedly
enhance growth of 2D.W303 cells, in that these cells grow
much better than 4D.W303 (Fig. 5B). Thus, they may con-
tribute to ceramide biosynthesis if Lac1p and Lac1p are
not operational. Under natural conditions YPC1 and
YDC1 may help cells to grow when they encounter inhibi-
tors such as Australifungin or Fumonisin B1 (Wang et al.,
1991; Mandala et al., 1995) by providing reverse cerami-
dase activity. As to their role as ceramidases, ypc1D cells
and ydc1D cells were reported to contain signiﬁcantly
more labelled IPCs after [3H]palmitate labelling, suggest-
ing that under physiological conditions, Ypc1p and Ydc1p
may continuously degrade part of ceramides, which oth-
erwise would be used for IPC biosynthesis (Mao et al.,
2000b). The presence of free C26:0-OH in wt cells
reported here suggests that normal cells degrade some of
their ceramides and that this degradation can be
increased in the presence of AbA (Fig. 7C). YPC1 and
YDC1 may have also some non-overlapping functions, as
their deletion does not generate the same phenotype, as
they show different genetic interactions and as they are
oppositely regulated by calcineurin (Mao et al., 2000b;
Yoshimoto et al., 2002; Schuldiner et al., 2005).
Our data establish, clarify or conﬁrm numerous aspects
concerning the speciﬁcity of the enzymes involved in
sphingolipid biosynthesis in yeast, which are mainly inter-
esting to the specialist. These aspects are detailed in
Supporting information.
Further studies will be required to fully appreciate the
roles of YPC1 and YDC1 in sphingolipid homeostasis of
eukaryotes.
Experimental procedures
Yeast strains, media, reagents
Strains used in this study are listed in Table 2. Cells were
grown on rich medium (YPD, YPG) or deﬁned minimal media
(SD, SG) containing 2% glucose (D) or galactose (G) as a
carbon source and uracil (U), adenine (A) and amino acids
(aa) at 30°C (Sherman, 2002). Media contained inositol
unless indicated otherwise. Alternatively, LM, a medium spe-
cially designed for cells unable to make sphingolipids, was
used (Pinto et al., 1992). Myriocin was from Sigma, St Louis,
MO, AbA from Takara Shuzo (Shiga, Japan).
Construction of strains
W303 lag1D lac1D cells proved to be highly unstable as many
clones, when labelled with [3H]inositol, displayed lipid proﬁles
quite different from the one previously found in the original
W303 lag1D lac1D strain and contained some new microso-
mal activity allowing to acylate [3H]DHS through an unchar-
acterized pathway (Guillas et al., 2001). Some clones started
to produce a major mild base-resistant lipid co-migrating with
M(IP)2C and/or ceased to make the residual amounts of
IPC/C, IPC/D, MIPC or the abnormal lipids a and b that had
Table 2. Strains and plasmids.
Name Genotype/type and markers Source/previous name
Strains
YPK9 MATa ade2-101 ochre his3-D200 leu2-D1 lys2-801 amber trp1-D63 ura3-52 Jiang et al. (1998)
YPK11 Same as YPK9, but MATa M. Jazwinski
2D.LAG1 Same as YPK9 but lac1D::LEU2 lag1D::TRP1 containing plasmid pBM150-LAG1 Guillas et al. (2001)
1D.YPC1 YPK9 lag1D::TRP1 kanr containing plasmid pPK183 for overexpression of Ypc1p M. Jazwinski
1D.YPC1 sur2D
(FBY1209)
Same as 1D.YPC1 but containing also sur2::KanMX4 This study
2D.YDC1 YPK9 lag1D::TRP1 lac1D::URA3 containing plasmid pJJ26 for
overexpression of Ydc1p
M. Jazwinski
3D.YDC1 (FBY1220) Same as 2D.YDC1, but containing also sur2::kanMX4 This study
ypc1D ydc1D (FBY1224) Same as YPK9 but ydc1::natMX ypc1::kanMX4 This study
BY4742 MATa his3D1 leu2D0 lys2D0 ura3D0 EUROSCARF collection
sur2D Same as BY4742, but containing sur2::kanMX4 EUROSCARF
vps4D Same as BY4742, but containing vps4::kanMX4 EUROSCARF
W303-1A MATa can1-100 ade2 his3-11,15 leu2-3,112 trp1-1 ura3-1 Guillas et al. (2001)
2D.W303-clone 17 can1-100 ade2 his3-11,15 leu2-3,112 trp1-1 ura3-1 lac1::LEU2 lag1::TRP1 This study
2D.W303-clone 19 can1-100 ade2 his3-11,15 leu2-3,112 trp1-1 ura3-1 lac1::LEU2 lag1::TRP1 This study
4D.W303 (FBY958) can1-100 ade2 his3-11,15 leu2-3,112 trp1-1 ura3-1 lac1::LEU2 lag1::TRP1
ydc1::natMX ypc1::kanMX4
This study
Plasmids
pPK183 2 m, YPC1 behind its own promoter, LEU2 Jiang et al. (2004)
pJJ26 2 m, YDC1 behind its own promoter, LEU2 Jiang et al. (2004)
pBM150-LAG1
named pPB5
in Jiang et al. (2004)
ARS1 CEN4 URA3 GAL1UAS-LAG1 Jiang et al. (1998)
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been found in the original W303 lag1D lac1D cells (not
shown). We concluded that these cells rapidly got outraced
by spontaneous suppressors, which survived freezing and
thawing better than unsuppressed cells, and that W303 lag1D
lac1D cells were genetically unstable and unsuitable to study
the effects of overexpression of YDC1. We therefore decided
to work in the YPK9 background, in which the lag1D lac1D
double deletion is lethal (Jiang et al., 1998), but which can be
maintained by pBM150-LAG1, a centromeric plasmid bearing
LAG1 under the control of the GAL1 promoter (Guillas et al.,
2001). The YPK9 lag1D lac1D pBM150-LAG1 (2D.LAG1)
strain grows at a normal rate on galactose and therefore is
probably not accumulating suppressors; when put on
glucose-containing media, cells undergo numerous cell divi-
sions but then switch to very slow growth. The YPK9 lag1D
lac1D rescued by overexpression of YDC1 (2D.YDC1) strain
was received from M. Jazwinski and constructed by deleting
LAC1 in YPK9 lag1D overexpressing YDC1 from plasmid
pJJ26 (Jiang et al., 2004). To obtain the YPK9 lag1D lac1D
sur2D strains overexpressing YDC1, we transfected a
sur2::kanMX4 cassette ampliﬁed from BY4742 sur2::kanMX4
(EUROSCARF) into 2D.YDC1. PCR was used to prepare
ydc1::natMX and ypc1::kanMX4 deletion cassettes. To obtain
the W303 lag1D lac1D ypc1D ydc1D strain, we deleted YPC1
and YDC1 in a W303 lag1D lac1D containing a galactose-
inducible LAG1 gene on the plasmid pBM150-LAG1. The
resulting W303 lag1D lac1D ypc1D ydc1D pBM150-LAG1
strain was grown in liquid LM with uracil for several weeks.
(5-Fluoroorotic acid counter-selection does not work on LM.)
After plating we isolated W303 lag1D lac1D ypc1D ydc1D
strains, which were uracil auxotroph and in which PCR analy-
sis showed that the pBM150-LAG1 had been lost. All dele-
tions were veriﬁed by PCR.
Cell labelling, lipid extraction, MMA treatment, NaOH
treatment and TLC
Unless stated otherwise, metabolic radiolabelling, cell disrup-
tion, lipid extraction and lipid analysis were performed as
described (Reggiori et al., 1997; Guillas et al., 2001). Ascend-
ing TLC on silica 60 gel glass plates was performed
with the following solvents: solvent 1 = chloroform :
methanol : NH4OH 40:10:1; solvents 2 and 3 = chloroform :
methanol : 0.25% KCl at ratios of 55:45:10 and 55:45:5
respectively. Radioactivity was detected by ﬂuorography and
quantiﬁed by one- or two-dimensional radioscanning in a
Berthold radioscanner.
Quantiﬁcation of LCBs
Quantiﬁcation of LCBs was performed as described (Merrill
et al., 1988).
Mass spectrometry analysis of lipid extracts
Exponentially growing cells (A600 of 1–2) were extracted as
described (Hanson and Lester, 1980), using procedure IIIB.
At this stage an equivalent amount of a similar lipid extract
from wt cells grown in [13C]glucose, supplemented with
[12C]inositol, was added as an internal standard. Aliquots in
CHCl3-CH3OH were heated and stirred at 65°C for 15 min to
solubilize M(IP)2C and immediately injected into a normal
phase PVA SIL HPLC column (YMC Europe GmbH, D-46514
Scherbeck, Germany, 1 ¥ 150 mm) eluted at 45 ml min-1. Sol-
vents A, hexane-isopropanol (98:2); B, CHCl3-isopropanol
(65:35); C, CH3OH were changed linearly over time to give
ratios A : B : C as follows: 0 min 100:0:0; 22 min 12:88:0;
30 min 10:74:16; 45 min 8:61:31; 50 through 65 min 0:0:100;
70 through 72.5 min 0:100:0; 75 through 82.5 min 100:0:0. To
improve sensitivity of ceramide detection the gradient was
modiﬁed to 0 min 12:88:0; 3 min 10:74:16; 4 min 8:61:31; 5
through 11 min 0:0:100; 13 min 0:100:0; 17 through 24 min
12:88:0. Ions in the effluent were ionized by electrospray
ionization with an electrode potential of 3500 volt and the
masses of negative ions were detected by a Bruker
Esquire-LC quadrupole ion trap mass spectrometer. The
signals from the well-known and well-resolved lipids of the 13C
internal standard were used to normalize the intensities of 12C
signals derived from the same or closely related lipids of the
test extract being analysed. Total ion counts represent the
integration of the particular ion throughout the elution region.
For detection of IPCs and ceramides, lipid extracts were
deacylated using methanolic NaOH and desalted. For glyc-
erophospholipid and sphingolipid detection, aliquots corre-
sponding to 0.01 and 0.15–1.0 A600 units of cells were injected
respectively.
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